Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Not a forecast

Rules 1.1.0 · as of 14 Sep 2026

Christian Angermayer · Said 5 Jun 2024 · angermayer-0182

Quote

Not a forecast

“The first "psychedelic drug", Spravato by Johnson & Johnson, has already been approved a while ago, showcasing that the challenges MDMA and other #psychedelics face can be successfully overcome.”
· Christian Angermayer on X: take on the FDA Advisory Committee vote against Lykos/MAPS MDMA therapy · tweet

In his thread on the FDA advisory committee vote against Lykos, he argues the regulatory obstacles facing MDMA and other psychedelics can be overcome, citing the earlier Spravato approval.

Descriptive, retrospective, or a statement of preference; no future state asserted.

← Earlier · Later → · All statements